Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for therapeutic monitoring

Journal of Pharmaceutical and Biomedical Analysis(2023)10.1016/j.jpba.2023.115932Source: DataRank Database

Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for therapeutic monitoring is a research paper published in Journal of Pharmaceutical and Biomedical Analysis (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.67)OA: greenTopics (51)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Patrick J. Oberly,Sharon A. Riddler ORCID,Thomas D. Nolin ORCID,Aaron S. Devanathan ORCID,Raymond E. West ORCID

Live enrichment

PubMed:38198884 PMC:PMC10922569 OpenAlex:https://openalex.org/W4390452025

NIH HHS

Grant: S10 OD028540

NIAID NIH HHS

Grant: P30 AI036219

NCRR NIH HHS

Grant: S10 RR023461

FWCI

0.67

Citation Percentile

0.7%

Citation Trend

2025

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10922569/pdf/nihms-1958092.pdf

publisherhttps://api.elsevier.com/content/article/PII:S073170852300701X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S073170852300701X?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10922569

Fields of Study

HIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsHIV Research and TreatmentHumansChromatography, High Pressure LiquidTandem Mass SpectrometryChromatography, LiquidAnti-Retroviral AgentsHIV InfectionsAcetonitrilesReproducibility of ResultsDrug Monitoring

MeSH Terms

AcetonitrilesChromatography, High Pressure LiquidChromatography, LiquidHumansReproducibility of ResultsHIV InfectionsDrug MonitoringAnti-Retroviral AgentsTandem Mass Spectrometry

Keywords

EmtricitabineChemistryChromatographyProtein precipitationTherapeutic drug monitoringBioanalysisAbacavirLamivudineTandem mass spectrometryAnalyteDolutegravirRaltegravirLiquid chromatography–mass spectrometryRepeatabilitySelected reaction monitoringHigh-performance liquid chromatographyDrugPharmacologyMass spectrometryHuman immunodeficiency virus (HIV)Antiretroviral therapyViral loadMedicineVirologyVirusHIVclinical pharmacologyConcentrationsAntiretroviralsUPLC-MS/MS

Sustainable Development Goals

SDG 0: Good health and well-being